• Users Online: 62
  • Print this page
  • Email this page
CASE REPORT
Year : 2022  |  Volume : 2  |  Issue : 3  |  Page : 682-684

Dorzolamide-induced giant cell thrombocytopenia: A case report of a hitherto unreported condition


1 Department of Ophthalmology, Consultant Glaucoma and Pediatric Ophthalmology Services Priyamvada Birla Aravind Eye Hospital, Kolkata, India
2 Department of Ophthalmology, Consultant Cataract & Glaucoma Services Charak Hospital & Research Centre, Lucknow, India
3 Department of Pathology, Consultant Patologist, Woodlands Multispeciality Hospital, Kolkata, India

Correspondence Address:
Dr. Komal Daljit Singh
Department of Ophthalmology, Consultant Cataract & Glaucoma Services Charak Hospital & Research Centre, Lucknow - 226 003
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_98_22

Rights and Permissions

Carbonic anhydrase inhibitors are frequently prescribed in topical and oral forms in various types of glaucoma. Dorzolamide eye drops are frequently associated with ocular side effects but systemic side effects are rare with its use. We report a case of dorzolamide-induced giant cell thrombocytopenia in a patient with post uveitic angle-closure glaucoma. After discontinuation of dorzolamide eye drops, the thrombocytopenia reversed.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed164    
    Printed0    
    Emailed0    
    PDF Downloaded31    
    Comments [Add]    

Recommend this journal